Average Co-Inventor Count = 7.55
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Roche Palo Alto LLC (4 from 322 patents)
2. Hoffmann-La Roche Inc. (3 from 4,948 patents)
3. Syntex (u.s.a.) Inc. (1 from 932 patents)
8 patents:
1. 10596173 - Combination therapy of an HBV capsid assembly inhibitor and an interferon
2. 10597380 - Pyridazinone-based broad spectrum anti-influenza inhibitors
3. 8648054 - 4'-substituted nucleoside derivatives as inhibitors of HCV RNA replication
4. 8071567 - 4'-substituted nucleoside derivatives as inhibitors of HCV RNA replication
5. 7915232 - 4'-substituted nucleoside derivatives as inhibitors of HCV RNA replication
6. 7608601 - 4'-Substituted nucleoside derivatives as inhibitors of HCV RNA replication
7. 6784166 - 4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication.
8. 6660721 - Anti-HCV nucleoside derivatives